Medical Research and Clinical Trials

MacroGenics Initiates Phase I Clinical Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

• Medical Research and Clinical Trials

MacroGenics Initiates Phase I Clinical Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Nana Muazin October 16, 2026

[City, State] – [Date] – MacroGenics, Inc., a biopharmaceutical company focused on developing innovative cancer immunotherapies and...

Read More Read more about MacroGenics Initiates Phase I Clinical Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Groundbreaking Research from OU Uncovers How Aggressive Breast Cancer Manipulates Immune System to Fuel Growth, Paving Way for Novel Therapies

• Medical Research and Clinical Trials

Groundbreaking Research from OU Uncovers How Aggressive Breast Cancer Manipulates Immune System to Fuel Growth, Paving Way for Novel Therapies

Azzam Bilal Chamdy October 16, 2026

Norman, OK – In a significant stride against one of the most formidable adversaries in oncology, researchers...

Read More Read more about Groundbreaking Research from OU Uncovers How Aggressive Breast Cancer Manipulates Immune System to Fuel Growth, Paving Way for Novel Therapies

Verastem Oncology Set to Advance KRAS Inhibitor VS-7375 to Phase III Trials Following Promising Data in Pancreatic, Colorectal, and Lung Cancers

• Medical Research and Clinical Trials

Verastem Oncology Set to Advance KRAS Inhibitor VS-7375 to Phase III Trials Following Promising Data in Pancreatic, Colorectal, and Lung Cancers

Nana Muazin October 16, 2026

[City, State] – [Date] – Verastem Oncology is poised to accelerate the development of its novel KRAS...

Read More Read more about Verastem Oncology Set to Advance KRAS Inhibitor VS-7375 to Phase III Trials Following Promising Data in Pancreatic, Colorectal, and Lung Cancers

University of Oklahoma Scientists Uncover Novel Mechanism: How Aggressive Breast Cancer Hijacks Immune System to Recruit Nerves, Fueling Growth

• Medical Research and Clinical Trials

University of Oklahoma Scientists Uncover Novel Mechanism: How Aggressive Breast Cancer Hijacks Immune System to Recruit Nerves, Fueling Growth

Nila Kartika Wati October 15, 2026

NORMAN, OK – In a significant breakthrough that could reshape the future of cancer treatment, researchers at...

Read More Read more about University of Oklahoma Scientists Uncover Novel Mechanism: How Aggressive Breast Cancer Hijacks Immune System to Recruit Nerves, Fueling Growth

Verastem Oncology Gears Up for Pivotal Phase III Trials of Promising KRAS Inhibitor VS-7375 Following Compelling Data Readout

• Medical Research and Clinical Trials

Verastem Oncology Gears Up for Pivotal Phase III Trials of Promising KRAS Inhibitor VS-7375 Following Compelling Data Readout

Pevita Pearce October 15, 2026

Boston, MA – October 14, 2026 – Verastem Oncology (NASDAQ: VSTM) announced today a significant stride forward...

Read More Read more about Verastem Oncology Gears Up for Pivotal Phase III Trials of Promising KRAS Inhibitor VS-7375 Following Compelling Data Readout

Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

• Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Jia Lissa October 15, 2026

NORMAN, OK – In a significant advancement for cancer research, scientists at the University of Oklahoma have...

Read More Read more about Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Vanda Pharmaceuticals Halts Social Anxiety Drug Program Amidst Trial Setback, Highlighting Industry-Wide Challenges

• Medical Research and Clinical Trials

Vanda Pharmaceuticals Halts Social Anxiety Drug Program Amidst Trial Setback, Highlighting Industry-Wide Challenges

Lina Irawan October 15, 2026

Washington D.C. – Vanda Pharmaceuticals has announced a significant pause in its late-stage clinical program for VQW-765,...

Read More Read more about Vanda Pharmaceuticals Halts Social Anxiety Drug Program Amidst Trial Setback, Highlighting Industry-Wide Challenges

Unveiling a Stealthy Alliance: OU Researchers Discover How Aggressive Breast Cancer Hijacks Immune Cells to Fuel Growth

• Medical Research and Clinical Trials

Unveiling a Stealthy Alliance: OU Researchers Discover How Aggressive Breast Cancer Hijacks Immune Cells to Fuel Growth

Asep Darmawan October 15, 2026

NORMAN, OK – In a significant breakthrough for cancer research, scientists at the University of Oklahoma (OU)...

Read More Read more about Unveiling a Stealthy Alliance: OU Researchers Discover How Aggressive Breast Cancer Hijacks Immune Cells to Fuel Growth

MHRA Unveils Ambitious "2030 Strategy" to Revolutionize Drug and Device Regulation, Championing AI and Patient-Centricity

• Medical Research and Clinical Trials

MHRA Unveils Ambitious "2030 Strategy" to Revolutionize Drug and Device Regulation, Championing AI and Patient-Centricity

Iffa Jayyana October 15, 2026

London, UK – The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a groundbreaking "2030...

Read More Read more about MHRA Unveils Ambitious "2030 Strategy" to Revolutionize Drug and Device Regulation, Championing AI and Patient-Centricity

Unveiling a Deceptive Alliance: OU Researchers Discover How Aggressive Breast Cancer Hijacks Immune Cells to Fuel Growth

• Medical Research and Clinical Trials

Unveiling a Deceptive Alliance: OU Researchers Discover How Aggressive Breast Cancer Hijacks Immune Cells to Fuel Growth

Neng Nana October 14, 2026

NORMAN, OK – In a significant breakthrough for cancer research, scientists at the University of Oklahoma (OU)...

Read More Read more about Unveiling a Deceptive Alliance: OU Researchers Discover How Aggressive Breast Cancer Hijacks Immune Cells to Fuel Growth